Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin effects on atherosclerosis biomarkers in T2DM and CAD
NCT01552018Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Mar 2012
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of saxagliptin in atherosclerosis, sponsored by Oslo University Hospital. Started Mar 2012; status: completed.
02
Drugs
saxagliptin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT01552018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01552018.